About Anne V. Eberhard
I am a medical student and currently doing research for my doctoral thesis at Stanford. My passion lies in human genomics, digital health and precision medicine, but also in the economical & political dimensions of healthcare.
Intro Content
Nature Nanotechnology
Trojan horse nanoparticles as a platform for the prevention of atherosclerotic cardiovascular disease.
The Leeper Lab ‘s goal is to develop innovative new therapies which will reduce the worldwide burden of atherosclerotic vascular disease. Our work is conducted in an interdisciplinary fashion, and spans the spectrum of ‘bench-to-bedside’ translation.